Mark Dempsey is an accomplished commercial leader with extensive experience in the pharmaceutical industry, currently serving as the International Commercial Lead for Lecanemab at Biogen since August 2020. Prior experience includes roles as Senior Director of Commercial Strategy at Sage Therapeutics and several leadership positions at Bristol-Myers Squibb, where substantial business growth and successful product launches were achieved. Mark has a solid educational background, holding a PhD in Pharmacology and a BSc(Hons) in Pharmacology & Biochemistry from University College Dublin, along with various marketing qualifications from prestigious institutions including INSEAD and CIM.
This person is not in the org chart
This person is not in any teams
This person is not in any offices